• Search
  • Basket
    You have no items in your basket

About BioMedical SIG

The objective of the SIG is to increase the translation of research results into solutions in human healthcare.

The aim of the SIG is to create a place to propose and discuss burning topics related to the SIG objective.

Examples of topics that we would like to explore:

  • Increase the awareness of researchers and KTOs in the bench-to-bedside process (maturation, clinical, regulatory, identification of a relevant need).
  • Increase the attractivity of early-stage research to investors.
  • Transition research from preclinical to clinical.
  • Train researchers and KTOs to interact and negotiate with pharma and VCs.
  • Increase the sustainability of biotech/Pharma practices by drug repurposing and use of natural products.

A subset of members of the BioMed SIG would like to create a group of stakeholders active in those fields to:

  • Identify main opportunities and challenges.
  • Generate guidelines (legal, IP, preclinical, regulatory) to be used as a reference.
  • Connect stakeholders with complementary needs to foster new collaborations.


Group Leaders

David Silvestre

David Silvestre

University of Liège, Belgium
Margaret Lawlor

Margaret Lawlor

University of Limerick, Ireland
Jérémie Langlet

Jérémie Langlet

Luxembourg Institute of Health, Luxembourg
Valeria Bergonzini

Valeria Bergonzini

Università di Modena e Reggio Emilia, Italy
Anna Stikane

Anna Stikane

Latvian Institute of Organic Synthesis, Latvia
Julia Gauglitz

Julia Gauglitz

University of Antwerp, Belgium
Inês Sobral Escoval

Inês Sobral Escoval

University of Coimbra, Portugal
Claudia Aguguo

Claudia Aguguo

University of Reading, UK

Other SIGs

Agrifood

Agrifood

The Agrifood SIG is a forum for knowledge transfer professionals to navigate and overcome some of the key challenges of commercialising research-based innovation across our global food supply chain.

Find out more
BioMedical

BioMedical

A group of ASTP members active in supporting researchers working in Human Life Science Research field.

Find out more
Digital Innovations

Digital Innovations

Launched as the Software SIG in 2016, the scope of the Digital Innovations (DI) SIG has broadened in recent years to encompass the full scope of digital innovations and how they impact on knowledge transfer…

Find out more
Directors' Forum

Directors' Forum

The Directors Forum SIG aims to exchange experiences between directors of a KTO. The themes mainly focus on the management of a KTO and all aspects that are involved.

Find out more
Legal

Legal

So much of our work involves legal questions and dilemmas. This SIG works to collect and share knowledge and experience. Join the SIG and their monthly meeting with different legal topics each month.

Find out more
New Professionals

New Professionals

The New Professionals SIG is an anchor point for individuals that are new to the field of Knowledge Transfer (KT) and Technology Transfer (TT). The SIG aims to help new professionals navigate the diverse…

Find out more
SHAPE

SHAPE

As many more universities and research institutions explore the possibilities of knowledge transfer and valorisation within the social sciences, humanities, and arts, this expert group keeps abreast of…

Find out more
Equity, Diversity and Inclusion (EDI)

Equity, Diversity and Inclusion (EDI)

The EDI SIG is open to all individuals, irrespective of how you identify, your level of seniority in your organisation, years of experience in the knowledge transfer sector or knowledge of matters relating…

Find out more
Spin-off

Spin-off

The objective of the SIG is to serve as a platform for in-depth discussions on supporting and nurturing spin-offs emerging from universities and research centres. This SIG aims to explore and share successful…

Find out more
Connect and Communicate with Impact (CCI)

Connect and Communicate with Impact (CCI)

The Connect & Communicate with Impact SIG brings together KT professionals to enhance communication excellence in knowledge transfer.

Find out more

BioMedical SIG Resources

Impact

BioMedical SIG #7

Philippe Tschopp explored how aligning manufacturing design with regulatory and clinical strategy enhances the development of oral solid drug products. He focused on GMP, GLP, and TPP as key components for ensuring quality, safety, and scalability.

Members only

Journals and Articles

New Frontiers in oncology: an evolving innovation ecosystem

A new study from the European Patent Office (EPO) explores how innovation ecosystems are shaping the future of oncology, with knowledge transfer playing a crucial role in bridging the gap between research and market-ready solutions. New Frontiers in Oncology: An Evolving Innovation Ecosystem provides a comprehensive analysis of patent trends in cancer-related technologies, revealing both the strengths and challenges facing Europe in this critical field.
Read

Impact

BioMedical SIG #6

Thomas Hanke (Evotec) shares his perspective on how to strategically plan and execute preclinical validation for translational academic research. Drawing on his experience at Evotec—a leading biotechnology company specialising in collaborative drug discovery—Hanke highlights best practices to align early-stage research with potential clinical applications.

Members only

Impact

BioMedical SIG #4

Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success. Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements.

Members only

Impact

BioMedical SIG #3

Join Katrina Bradley and BioMedical SIG for a webinar on market access strategies in life sciences. Learn to plan, execute, and optimise early tech deployment.

Members only

Impact

BioMedical SIG #2

Second webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences. This webinar will focus on the process involved with the release of new medical devices.

Members only

How to initiate a SIG?

Do you have a specialist interest, a burning issue, or a brilliant insight which you would like to share with the ASTP community? This guide book explains how you can initiate a Special Interest Group (SIG) with the help of HQ and your ASTP colleagues.

Download the Guide